Correlation Between Karyopharm Therapeutics and Surrozen Warrant
Can any of the company-specific risk be diversified away by investing in both Karyopharm Therapeutics and Surrozen Warrant at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Karyopharm Therapeutics and Surrozen Warrant into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Karyopharm Therapeutics and Surrozen Warrant, you can compare the effects of market volatilities on Karyopharm Therapeutics and Surrozen Warrant and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Karyopharm Therapeutics with a short position of Surrozen Warrant. Check out your portfolio center. Please also check ongoing floating volatility patterns of Karyopharm Therapeutics and Surrozen Warrant.
Diversification Opportunities for Karyopharm Therapeutics and Surrozen Warrant
-0.57 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Karyopharm and Surrozen is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Karyopharm Therapeutics and Surrozen Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Surrozen Warrant and Karyopharm Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Karyopharm Therapeutics are associated (or correlated) with Surrozen Warrant. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Surrozen Warrant has no effect on the direction of Karyopharm Therapeutics i.e., Karyopharm Therapeutics and Surrozen Warrant go up and down completely randomly.
Pair Corralation between Karyopharm Therapeutics and Surrozen Warrant
Given the investment horizon of 90 days Karyopharm Therapeutics is expected to under-perform the Surrozen Warrant. But the stock apears to be less risky and, when comparing its historical volatility, Karyopharm Therapeutics is 21.99 times less risky than Surrozen Warrant. The stock trades about -0.65 of its potential returns per unit of risk. The Surrozen Warrant is currently generating about 0.29 of returns per unit of risk over similar time horizon. If you would invest 1.47 in Surrozen Warrant on September 25, 2024 and sell it today you would earn a total of 1.52 from holding Surrozen Warrant or generate 103.4% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 66.67% |
Values | Daily Returns |
Karyopharm Therapeutics vs. Surrozen Warrant
Performance |
Timeline |
Karyopharm Therapeutics |
Surrozen Warrant |
Karyopharm Therapeutics and Surrozen Warrant Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Karyopharm Therapeutics and Surrozen Warrant
The main advantage of trading using opposite Karyopharm Therapeutics and Surrozen Warrant positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Karyopharm Therapeutics position performs unexpectedly, Surrozen Warrant can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Surrozen Warrant will offset losses from the drop in Surrozen Warrant's long position.Karyopharm Therapeutics vs. X4 Pharmaceuticals | Karyopharm Therapeutics vs. Hookipa Pharma | Karyopharm Therapeutics vs. Mereo BioPharma Group | Karyopharm Therapeutics vs. Acumen Pharmaceuticals |
Surrozen Warrant vs. Fate Therapeutics | Surrozen Warrant vs. Caribou Biosciences | Surrozen Warrant vs. Karyopharm Therapeutics | Surrozen Warrant vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |